Folinic acid in colorectal cancer: esquire or fellow knight? Real-world results from a mono institutional, retrospective study

The stock of therapeutic weapons available in metastatic colorectal cancer (mCRC) has been progressively grown over the years, with improving both survival and patients' clinical outcome: notwithstanding advances in the knowledge of mCRC biology, as well as advances in treatment, fluoropyrimidi...

Descripción completa

Detalles Bibliográficos
Autores principales: Romano, Francesco Jacopo, Barbato, Carmela, Biglietto, Maria, Di Lauro, Vincenzo, Arundine, Dario, Fiorentino, Roberto, Ambrosio, Francesca, Cammarota, Maresa, Chiurazzi, Bruno, Puglia, Livio, Scagliarini, Sarah, Ruocco, Raffaella, Mocerino, Carmen, Cerillo, Ivana, Brangi, Maria Fiorella, Riccardi, Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869580/
https://www.ncbi.nlm.nih.gov/pubmed/33613849
http://dx.doi.org/10.18632/oncotarget.27872

Ejemplares similares

Ejemplares similares